source
- DHL in talks with major pharma firms to manage sites amid ongoing trade disruptionsDHL's healthcare logistics division is currently in discussions with several leading pharmaceutical manufacturers. The drugmakers are exploring options for DHL to either assume control of their ma…
- Summit Therapeutics cancels $500 million public offering amid weak market conditionsSummit Therapeutics announced it is no longer pursuing a $500 million public offering, citing unfavorable market conditions. The biotech sector has recently seen record‑setting initial public offe…